Correlation Between Landos Biopharma and Eyenovia
Can any of the company-specific risk be diversified away by investing in both Landos Biopharma and Eyenovia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Landos Biopharma and Eyenovia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Landos Biopharma and Eyenovia, you can compare the effects of market volatilities on Landos Biopharma and Eyenovia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Landos Biopharma with a short position of Eyenovia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Landos Biopharma and Eyenovia.
Diversification Opportunities for Landos Biopharma and Eyenovia
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Landos and Eyenovia is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Landos Biopharma and Eyenovia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eyenovia and Landos Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Landos Biopharma are associated (or correlated) with Eyenovia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eyenovia has no effect on the direction of Landos Biopharma i.e., Landos Biopharma and Eyenovia go up and down completely randomly.
Pair Corralation between Landos Biopharma and Eyenovia
If you would invest 402.00 in Landos Biopharma on August 24, 2024 and sell it today you would earn a total of 0.00 from holding Landos Biopharma or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 4.35% |
| Values | Daily Returns |
Landos Biopharma vs. Eyenovia
Performance |
| Timeline |
| Landos Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Eyenovia |
Landos Biopharma and Eyenovia Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Landos Biopharma and Eyenovia
The main advantage of trading using opposite Landos Biopharma and Eyenovia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Landos Biopharma position performs unexpectedly, Eyenovia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyenovia will offset losses from the drop in Eyenovia's long position.| Landos Biopharma vs. Apollomics Class A | Landos Biopharma vs. Cardio Diagnostics Holdings | Landos Biopharma vs. Transcode Therapeutics | Landos Biopharma vs. Xenetic Biosciences |
| Eyenovia vs. Reviva Pharmaceuticals Holdings | Eyenovia vs. Cidara Therapeutics | Eyenovia vs. Fortress Biotech | Eyenovia vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |